{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:48:52Z","timestamp":1781416132625,"version":"3.54.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The Kelch-like ECH-associated protein 1\u2013nuclear factor erythroid 2-related factor 2 (KEAP1\u2013NRF2) system plays a central role in redox homeostasis and inflammation control. Oxidative stress or electrophilic compounds promote NRF2 stabilization and transcriptional activity by negatively regulating its inhibitor, KEAP1. We have previously reported that bromovalerylurea (BU), originally developed as a hypnotic, exerts anti-inflammatory effects in various inflammatory disease models. However, the molecular mechanism underlying its effect remains uncertain. Herein, we found that by real-time multicolor luciferase assay using stable luciferase red3 (SLR3) and green-emitting emerald luciferase (ELuc), BU potentiates NRF2-dependent transcription in the human hepatoblastoma cell line HepG2 cells, which lasted for more than 60\u00a0h. Further analysis revealed that BU promotes NRF2 accumulation and the transcription of its downstream cytoprotective genes in the HepG2 and the murine microglial cell line BV2. Keap1 knockdown did not further enhance NRF2 activity, suggesting that BU upregulates NRF2 by targeting KEAP1. Knockdown of Nfe2l2 in BV2 cells diminished the suppressive effects of BU on the production of pro-inflammatory mediators, like nitric oxide (NO) and its synthase NOS2, indicating the involvement of NRF2 in the anti-inflammatory effects of BU. These data collectively suggest that BU could be repurposed as a novel NRF2 activator to control inflammation and oxidative stress.<\/jats:p>","DOI":"10.1093\/jb\/mvad030","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:11:23Z","timestamp":1681211483000},"page":"131-142","source":"Crossref","is-referenced-by-count":12,"title":["The anti-inflammatory and anti-oxidative effect of a classical hypnotic bromovalerylurea mediated by the activation of NRF2"],"prefix":"10.1093","volume":"174","author":[{"given":"Haruna","family":"Takeda","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University , 454, Shitsukawa, Toon, Ehime, 791-0295, Japan"},{"name":"Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University , 4-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST) , 2 217-14, Hayashi-cho, Takamatsu, Kagawa, 761-0301, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University , 454, Shitsukawa, Toon, Ehime, 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University , 454, Shitsukawa, Toon, Ehime, 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University , 454, Shitsukawa, Toon, Ehime, 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Nagashio","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University , 454, Shitsukawa, Toon, Ehime, 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University , 4-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hozumi","family":"Motohashi","sequence":"additional","affiliation":[{"name":"Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University , 4-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, 454, Shitsukawa , Toon, Ehime, 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University , 454, Shitsukawa, Toon, Ehime, 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"2024030619355375600_ref1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"2024030619355375600_ref2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1759720X12467868","article-title":"Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations","volume":"5","author":"Sokolove","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2024030619355375600_ref3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","article-title":"The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)","volume":"71","author":"Siti","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"2024030619355375600_ref4","first-page":"1","article-title":"A perspective on Nrf2 Signaling pathway for Neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"15","author":"Saha","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"2024030619355375600_ref5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"2024030619355375600_ref6","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/antiox10121929","article-title":"The KEAP1-NRF2 system in healthy aging and longevity","volume":"10","author":"Matsumaru","year":"2021","journal-title":"Antioxidants"},{"key":"2024030619355375600_ref7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/MCB.00868-15","article-title":"Characterizations of three major cysteine sensors of Keap1 in stress response","volume":"36","author":"Saito","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"2024030619355375600_ref8","doi-asserted-by":"crossref","first-page":"16817","DOI":"10.1074\/jbc.R117.800169","article-title":"Stress-sensing mechanisms and the physiological roles of the Keap1\u2013Nrf2 system during cellular stress","volume":"292","author":"Suzuki","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2024030619355375600_ref9","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1128\/MCB.00700-06","article-title":"BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress","volume":"26","author":"Zhang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2024030619355375600_ref10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.gene.2016.03.058","article-title":"Small Maf proteins (MafF, MafG, MafK): history, structure and function","volume":"586","author":"Katsuoka","year":"2016","journal-title":"Gene"},{"key":"2024030619355375600_ref11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MCB.00785-15","article-title":"The mediator subunit MED16 transduces NRF2-activating signals into antioxidant gene expression","volume":"36","author":"Sekine","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"2024030619355375600_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"2024030619355375600_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","volume":"2019","author":"Robledinos-Ant\u00f3n","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"2024030619355375600_ref14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tips.2020.07.003","article-title":"Can activation of NRF2 be a strategy against COVID-19?","volume":"41","author":"Cuadrado","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"2024030619355375600_ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458520949158","article-title":"Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients","volume":"28","author":"Jordan","year":"2022","journal-title":"Mult. Scler. J."},{"key":"2024030619355375600_ref16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01940972","article-title":"Studien \u00fcber die hypnotische Wirkung in der Va\u00eferian-s\u00fcuregruppe","volume":"57","author":"Eeckhout","year":"1907","journal-title":"Arch.Exp.Path.und Pharmak."},{"key":"2024030619355375600_ref17","doi-asserted-by":"crossref","first-page":"752.e1","DOI":"10.1016\/j.ajem.2008.09.044","article-title":"Ataxia associated with spurious hyperchloremia: the one behind the scene","volume":"27","author":"Yan","year":"2009","journal-title":"Am. J. Emerg. Med."},{"key":"2024030619355375600_ref18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12883-022-02712-3","article-title":"Bromisoval-induced bromism with status epilepticus mimicking Wernicke\u2019s encephalopathy: report of two cases","volume":"22","author":"Biyajima","year":"2022","journal-title":"BMC Neurol."},{"key":"2024030619355375600_ref19","first-page":"143","article-title":"Transition of psychotropic drugs in Japanese pharmacopoeia (JP) (part 16). Transitions in the standards and test methods of bromovalerylurea in JP V (1932) and JP X VI (2011), and comparison with Deutsches Arzneibuch","volume":"50","author":"Yanagisawa","year":"2015","journal-title":"Yakushigaku Zassi"},{"key":"2024030619355375600_ref20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbrc.2015.02.111","article-title":"The ameliorative effects of a hypnotic bromvalerylurea in sepsis","volume":"459","author":"Kikuchi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2024030619355375600_ref21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuint.2016.06.013","article-title":"The hypnotic bromovalerylurea ameliorates 6-hydroxydopamine-induced dopaminergic neuron loss while suppressing expression of interferon regulatory factors by microglia","volume":"99","author":"Higaki","year":"2016","journal-title":"Neurochem. Int."},{"key":"2024030619355375600_ref22","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/glia.23469","article-title":"Comparison of the detrimental features of microglia and infiltrated macrophages in traumatic brain injury: a study using a hypnotic bromovalerylurea","volume":"66","author":"Abe","year":"2018","journal-title":"Glia"},{"key":"2024030619355375600_ref23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2015.07.010","article-title":"Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: suppression of NF\u03baB nuclear translocation and subsequent STAT1 phosphorylation","volume":"90","author":"Ishii","year":"2015","journal-title":"Neurochem. Int."},{"key":"2024030619355375600_ref24","doi-asserted-by":"crossref","first-page":"e10011","DOI":"10.1371\/journal.pone.0010011","article-title":"Enhanced beetle luciferase for high-resolution bioluminescence imaging","volume":"5","author":"Nakajima","year":"2010","journal-title":"PLoS One"},{"key":"2024030619355375600_ref25","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/bi9900830","article-title":"Cloning, sequence analysis, and expression of active Phrixothrix railroad-worms luciferases: relationship between bioluminescence spectra and primary structures","volume":"38","author":"Viviani","year":"1999","journal-title":"Biochemistry"},{"key":"2024030619355375600_ref26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/bio.3454","article-title":"Bioluminescence-based cytotoxicity assay for simultaneous evaluation of cell viability and membrane damage in human hepatoma HepG2 cells","volume":"33","author":"Uno","year":"2018","journal-title":"Luminescence"},{"key":"2024030619355375600_ref27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fct.2017.06.039","article-title":"Antioxidant properties of 5-hydroxy-4-phenyl-butenolide via activation of Nrf2\/ARE signaling pathway","volume":"107","author":"Tabei","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"2024030619355375600_ref28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ab.2017.01.015","article-title":"Correlation between luminescence intensity and cytotoxicity in cell-based cytotoxicity assay using luciferase","volume":"522","author":"Wakuri","year":"2017","journal-title":"Anal. Biochem."},{"key":"2024030619355375600_ref29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2144\/05386ST03","article-title":"Multicolor luciferase assay system: one-step monitoring of multiple gene expressions with a single substrate","volume":"38","author":"Nakajima","year":"2005","journal-title":"BioTechniques"},{"key":"2024030619355375600_ref30","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1021\/bi100545h","article-title":"Dual-color luciferase mouse directly demonstrates coupled expression of two clock genes","volume":"49","author":"Noguchi","year":"2010","journal-title":"Biochemistry"},{"key":"2024030619355375600_ref31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2017.03.007","article-title":"Elevated Na+\/H+ exchanger-1 expression enhances the metastatic collective migration of head and neck squamous cell carcinoma cells","volume":"486","author":"Kaminota","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2024030619355375600_ref32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jphs.2017.05.007","article-title":"Effects of hypnotic bromovalerylurea on microglial BV2 cells","volume":"134","author":"Kawasaki","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"2024030619355375600_ref33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbadis.2017.12.022","article-title":"Sustained anti-inflammatory effects of TGF-\u03b21 on microglia\/macrophages","volume":"1864","author":"Islam","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"2024030619355375600_ref34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidatives stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"2024030619355375600_ref35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"2024030619355375600_ref36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.expneurol.2008.08.001","article-title":"Blockade of microglial glutamate release protects against ischemic brain injury","volume":"214","author":"Takeuchi","year":"2008","journal-title":"Exp. Neurol."},{"key":"2024030619355375600_ref37","first-page":"73","article-title":"Microglia and ischemic stroke: a double-edged sword","volume":"5","author":"Patel","year":"2013","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"2024030619355375600_ref38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jphs.2020.11.007","article-title":"Microglial metabolic disturbances and neuroinflammation in cerebral infarction","volume":"145","author":"Takeda","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"2024030619355375600_ref39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"2024030619355375600_ref40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/jb\/mvac014","article-title":"NRF2 pathway activation attenuates ageing-related renal phenotypes due to \u03b1-klotho deficiency","volume":"171","author":"Zhao","year":"2022","journal-title":"The Journal of Biochemistry"},{"key":"2024030619355375600_ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.889226","article-title":"Curcumin restrains oxidative stress of after Intracerebral Hemorrhage in rat by activating the Nrf2\/HO-1 pathway","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"2024030619355375600_ref42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40263-014-0155-5","article-title":"Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis","volume":"28","author":"Burness","year":"2014","journal-title":"CNS Drugs"},{"key":"2024030619355375600_ref43","doi-asserted-by":"crossref","first-page":"175025","DOI":"10.1016\/j.ejphar.2022.175025","article-title":"Dimethyl fumarate : a review of preclinical efficacy in models of neurodegenerative diseases","volume":"926","author":"Majkutewicz","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"2024030619355375600_ref44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","article-title":"Regulation of Nrf2 - an update","volume":"66","author":"Niture","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"2024030619355375600_ref45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hesc\/9780199270293.001.0001","volume-title":"ORGANIC CHEMISTRY","author":"Clayden","year":"2012","edition":"2nd"},{"key":"2024030619355375600_ref46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"2024030619355375600_ref47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["The Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jb\/advance-article-pdf\/doi\/10.1093\/jb\/mvad030\/50497260\/mvad030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/174\/2\/131\/56832425\/mvad030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/174\/2\/131\/56832425\/mvad030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T14:36:40Z","timestamp":1709735800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jb\/article\/174\/2\/131\/7114021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4,11]]},"published-print":{"date-parts":[[2023,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jb\/mvad030","relation":{},"ISSN":["0021-924X","1756-2651"],"issn-type":[{"value":"0021-924X","type":"print"},{"value":"1756-2651","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,4,11]]}}}